Skip to content

Follow-up assessment of patients with COVID-19 by using multinuclear MRI

Follow-up assessment of patients with COVID-19 by using multinuclear MRI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067776
Enrollment
Unknown
Registered
2023-01-23
Start date
2023-03-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Patients with COVID-19 group:N/A
control group:N/A

Sponsors

Wuhan Jinyintan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 85, with the ability of independent behavior; 2. People infected with COVID-19 from January 2023 to December 2024; Or volunteers with no history of chronic lung disease and no history of pneumonia due to COVID-19 infection (including control volunteers who participated in the Long-Term Prognosis Follow-up Study for Asymptomatic COVID-19 Patients); Or have a history of pneumonia caused by COVID-19 infection and have participated in pulmonary gas MRI clinical follow-up; 3. Agree to participate in the clinical trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Electronic implants, such as cardiac pacemakers, nerve stimulators, insulin pumps, cochlear implants, etc.; 2. Patients with aneurysm surgery and intracranial aneurysm clip; 3. People who have had heart surgery and artificial heart valves; 4. There are metal foreign bodies, metal implants or metal prostheses in the body; 5. Pregnant and lactating women and those who have family planning; 6. Critically ill patients requiring the use of life support system; 7. Uncontrolled epilepsy or mental illness, unable to cooperate with MRI examination; 8. Severe claustrophobia, unable to cooperate with magnetic resonance examination; 9. Patients who cannot inhale and hold their breath normally; 10. Other conditions that the clinical trial personnel consider inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
Pulmonary fucntion tests;Pulmonary ventilation imaging;Lung gas DWI;Gas exchange function;Questionnaire survey;Chest CT;Brain MRI;Routine blood tests;Clinical chemistry analysis;

Countries

China

Contacts

Public ContactChaolin Huang

Wuhan Jinyintan Hospital

88071718@qq.com+86 153 0717 3189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026